Kaisa Health Group Holdings Limited (HK:0876)
:0876
Top Page
Kaisa Health Group Holdings Limited
(0876)
Select Model
Select Model
Rating:47Neutral
Price Target:
HK$0.17
▲(88.89% Upside)
Action:ReiteratedDate:01/15/26
The score is held back primarily by weak financial performance (ongoing losses and poor operating/free cash flow), with only partial support from a low-leverage, cash-backed balance sheet. Technicals are strong but appear overbought, and valuation support is limited due to losses and no dividend data.
Positive Factors
Low leverage and liquidity buffer
A very low debt load and cash exceeding debt provide durable financial flexibility: the company can fund operations, endure revenue shortfalls, or pursue strategic investments without urgent refinancing. This reduces solvency risk and supports multi-quarter resilience.
Negative Factors
Persistent net losses
Ongoing net losses erode equity and limit reinvestment capacity. Over months, sustained deficits can force dilutive capital raises or spending cuts, undermining long-term strategic initiatives and making a durable path to profitability imperative for viability.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage and liquidity buffer
A very low debt load and cash exceeding debt provide durable financial flexibility: the company can fund operations, endure revenue shortfalls, or pursue strategic investments without urgent refinancing. This reduces solvency risk and supports multi-quarter resilience.
Read all positive factors
Kaisa Health Group Holdings Limited (0876) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$615.14M
Dividend YieldN/A
Average Volume (3M)76.64M
Price to Earnings (P/E)―
Beta (1Y)1.28
Revenue Growth-8.46%
EPS Growth45.13%
CountryHK
Employees861
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding5,042,139,000
10 Day Avg. Volume53,429,215
30 Day Avg. Volume76,644,739
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.28
Price to Sales (P/S)0.65
P/FCF Ratio-3.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Kaisa Health Group Holdings Limited Business Overview & Revenue Model
Company Description
Kaisa Health Group Holdings Limited, an investment holding company, manufactures and trades in dental prosthetics in the People's Republic of China and internationally. The company offers dental prosthetics, including crowns and bridges, removable...
How the Company Makes Money
Kaisa Health Group Holdings Limited generates revenue through several key streams. Primarily, the company earns income from the sale of health supplements and wellness products, which are marketed through various retail and online channels. Additi...
Kaisa Health Group Holdings Limited Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
40
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 166.42M | 185.36M | 185.88M | 191.50M | 209.63M | 183.81M |
| Gross Profit | 69.20M | 81.86M | 81.07M | 82.56M | 97.42M | 89.96M |
| EBITDA | -18.85M | -12.70M | 27.56M | -132.02M | 45.58M | -20.71M |
| Net Income | -31.22M | -46.35M | 7.47M | -123.32M | 2.36M | -39.69M |
Balance Sheet | ||||||
| Total Assets | 513.07M | 517.59M | 605.07M | 767.60M | 971.33M | 757.54M |
| Cash, Cash Equivalents and Short-Term Investments | 146.95M | 149.61M | 174.08M | 173.45M | 259.26M | 176.60M |
| Total Debt | 11.37M | 10.65M | 18.00M | 31.87M | 32.28M | 23.24M |
| Total Liabilities | 82.16M | 91.10M | 113.30M | 296.69M | 288.49M | 110.04M |
| Stockholders Equity | 435.90M | 431.15M | 492.01M | 485.33M | 651.12M | 636.52M |
Cash Flow | ||||||
| Free Cash Flow | -10.46M | -37.31M | -45.51M | -81.53M | -137.09M | -59.42M |
| Operating Cash Flow | -7.59M | -32.32M | -34.64M | -67.53M | -122.00M | -29.18M |
| Investing Cash Flow | 15.64M | 23.42M | 44.50M | 2.02M | 141.67M | -21.66M |
| Financing Cash Flow | -3.14M | -7.82M | -7.34M | -7.08M | 70.09M | -6.59M |
Kaisa Health Group Holdings Limited Technical Analysis
Negative
0.09
Price Trends
0.17
Negative
0.13
Negative
0.08
Positive
Market Momentum
-0.02
Positive
39.55
Neutral
32.76
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0876, the sentiment is Negative. The current price of 0.09 is below the 20-day moving average (MA) of 0.15, below the 50-day MA of 0.17, and above the 200-day MA of 0.08, indicating a neutral trend. The MACD of -0.02 indicates Positive momentum. The RSI at 39.55 is Neutral, neither overbought nor oversold. The STOCH value of 32.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0876.
Kaisa Health Group Holdings Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$1.56B | 6.78 | 3.68% | 7.46% | 21.39% | -0.57% | |
73 Outperform | HK$7.10B | 20.75 | 10.41% | ― | 14.06% | 3.02% | |
72 Outperform | HK$23.41B | 14.57 | 24.01% | 0.63% | 13.58% | 24.59% | |
68 Neutral | HK$17.37B | 13.02 | 6.64% | 4.58% | 0.74% | 2.13% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | HK$615.14M | -7.56 | ― | ― | -8.46% | 45.13% |
* Healthcare Sector Average
HK:0876
Kaisa Health Group Holdings Limited
0.12
0.10
351.85%
HK:1066
Shandong Weigao Group Medical Polymer Co
3.84
-1.98
-34.04%
HK:1358
PW Medtech Group Ltd.
1.06
0.07
7.40%
HK:1501
Shanghai Kindly Medical Instruments Co., Ltd. Class H
33.64
6.64
24.59%
HK:2276
Shanghai Conant Optical Co. Ltd. Class H
46.18
20.36
78.85%
Kaisa Health Group Holdings Limited Corporate Events
Kaisa Health Announces Name Change of External Auditor
Jan 14, 2026
Kaisa Health Group Holdings Limited has announced that its external auditor has formally changed its English name from SFAI (HK) CPA Limited to ZSZH (HK) Fuson CPA Limited, with a corresponding change in its Chinese name effective 9 January 2026. ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.